Fourier

Fourier is a global robotics company developing intelligent humanoid and rehabilitation robots for real-world applications—from mobility assistance to industrial tasks. Its GRx humanoid series (GR-1 and GR-2) feature human-like dexterity, full-body motion control, and advanced vision systems using 3D occupancy mapping and transformer-based environmental perception. On the medical side, Fourier Rehab offers robotic solutions like the ArmMotus and ExoMotus for neurorehabilitation. Its robots are equipped with proprietary FSA actuators, AI vision, and tactile sensors to support everything from upper-limb therapy to autonomous warehouse navigation.

Fourier offers a flexible mix of direct sales and subscription-based pricing depending on the application and customer segment. For GRx humanoids, pricing is largely CapEx-driven, aimed at research labs, developers, and enterprises integrating robotics into real-world workflows. However, in the rehabilitation sector, Fourier Rehab leans into a hardware-as-a-service (HaaS) model, bundling equipment with ongoing support, software updates, and clinical guidance. This hybrid approach—part CapEx, part technology-as-a-service—makes robotics more financially accessible to hospitals and R&D partners while allowing Fourier to evolve its systems through usage-driven data collection and continuous improvement.